Get the content you want anytime you want.
The Annual Conference on Retroviruses and Opportunistic Infections (CROI 2019)

Select coverage from The Annual Conference on Retroviruses and Opportunistic Infections (CROI 2019) is included below:

Successes of Point-of-Care Viral Load Testing
Paul Drain, MD, MPH, explains how point-of-care viral load testing was successful in providing rapid results to patients in a South African-based study.
PopART Shows Promise for Reducing New HIV Infections
A communitywide HIV prevention package including in-home testing and antiretroviral therapy reduces new infections, according to a study from the HIV Prevention Trials Network.
Top 5 Key Takeaways from CROI 2019
CROI 2019 was held March 4-7, 2018, in Seattle, Washington. The conference featured results of new studies on a variety of HIV topics as well as advancements being made in the field. Here are 5 key takeaways from the meeting. 
How Providers Can Help Prevent PrEP Resistance
Kavita Misra, PhD, MPH, explains how health care providers can help prevent PrEP resistance from growing by increasing screening for acute HIV infection.
Barriers to PrEP Use
Julia Marcus, PhD, MPH, discusses the barriers of PrEP use and how current prescribing guidelines are used in clinical practice. 
Exploring the Link Between Antiretroviral Therapy and Weight Gain
Paul Sax, MD, details his research on integrase inhibitor-based regimens and weight gain. 
Takeaways from CROI 2019: Part 2
From the London Patient to the DISCOVER trial and everything in between, HIV experts provide their biggest takeaways from CROI 2019, in the second part of our highlight reel.
Hepatitis C Rates Drop Drastically in London Residents With HIV
A London study shows that men infected with HIV are acquiring HCV at much lower levels than before.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?